You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Drug Price Trends for TUSSIN DM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TUSSIN DM

Average Pharmacy Cost for TUSSIN DM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-01 0.01847 ML 2025-03-26
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-02 0.01762 ML 2025-03-19
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-02 0.01758 ML 2025-02-19
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-02 0.01748 ML 2025-01-22
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-02 0.01764 ML 2024-12-18
TUSSIN DM 400-20 MG/20 ML LIQ 70000-0628-02 0.01722 ML 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Tussin DM

Introduction to Tussin DM

Tussin DM is a widely used over-the-counter (OTC) medication that combines dextromethorphan, a cough suppressant, and guaifenesin, an expectorant. This combination is designed to relieve coughs and help loosen phlegm and thin bronchial secretions, making it easier to expel mucus from the bronchial tubes.

Market Drivers

Increasing Prevalence of Respiratory Conditions

The global market for Tussin DM and similar medications is driven by the increasing prevalence of respiratory conditions such as the common cold, flu, bronchitis, and allergies. These conditions lead to a higher demand for cough medications, which in turn boosts the sales of Tussin DM and other dextromethorphan/guaifenesin combinations[3].

Growing Consumer Awareness and Self-Medication

With greater access to healthcare information, consumers are more inclined towards self-medication practices. This trend increases the demand for OTC medications like Tussin DM, as individuals seek quick relief from cough symptoms without a prescription[3].

Regulatory Environment

The strict regulations against the use of codeine in many countries have created an opportunity for non-opioid expectorants like guaifenesin. This shift in regulatory landscape is expected to drive the growth of the guaifenesin market, which directly benefits Tussin DM and similar products[1].

Market Trends

Product Type and Dosage Forms

Tussin DM is available in various dosage forms, including oral liquids and tablets. The OTC segment dominates the market due to high demand for these convenient and accessible products. The oral liquid form of Tussin DM, in particular, is popular due to its ease of administration, especially for pediatric and geriatric patients[3][5].

Regional Market Dynamics

North America is a significant market for Tussin DM, driven by a strong base of healthcare facilities and the presence of major pharmaceutical companies. However, the Asia-Pacific region is expected to witness significant growth due to increasing government initiatives, rising healthcare facilities, and a large population pool seeking quality healthcare[3].

Price Projections

Current Pricing

The cost of Tussin DM varies depending on the pharmacy and the specific formulation. For example, the oral liquid form of Tussin DM (20 mg-200 mg/20 mL) can cost around $11 for a supply of 118 milliliters. Similarly, Q-Tussin DM (10 mg-100 mg/5 mL) can cost around $9 for a supply of 120 milliliters[2][5].

Future Pricing Trends

Given the increasing demand for OTC cough medications and the growing market size, prices are likely to remain stable or see a slight increase. However, competition from generic versions and other brands may keep prices in check. The availability of discount cards and patient assistance programs can also help reduce the cost for consumers[2][5].

Competitive Landscape

Key Market Players

The market for Tussin DM and similar products is competitive, with several key players involved. Companies like Perrigo Company plc., Synthokem Labs Pvt. Ltd., Yuan Cheng Group, and others are active in the guaifenesin and dextromethorphan markets. The approval and launch of new products, such as Mucinex DM Maximum Strength, further intensify the competition[1].

Generic and Branded Products

The availability of generic versions of Tussin DM, such as dextromethorphan/guaifenesin combinations, provides consumers with cost-effective alternatives. This competition from generics can influence pricing strategies for branded products, potentially leading to more competitive pricing in the market[2][5].

Regulatory and Legal Considerations

FDA Approvals and Compliance

Products like Tussin DM must comply with FDA regulations. For instance, Perrigo Company plc. received FDA approval for Mucinex DM Maximum Strength, which is a similar product. Compliance with regulatory standards is crucial for market presence and growth[1].

Patient Safety and Overdose Prevention

Regulations also focus on patient safety, with clear instructions on the packaging to keep the medication out of reach of children and to seek medical help in case of overdose. These measures are essential for maintaining consumer trust and ensuring the safe use of the medication[4].

Market Restraints

Availability of Substitutes

One of the significant restraints for the Tussin DM market is the availability of many substitutes. Other cough suppressants and expectorants can compete with Tussin DM, potentially affecting its market share. Additionally, stringent regulations against cough suppressants can also impact the market growth[1].

Economic Factors

Economic factors such as stock shortages and fluctuations in raw material costs can influence the pricing and availability of Tussin DM. These variables can affect the overall market dynamics and consumer purchasing decisions[2][5].

Key Takeaways

  • Increasing Demand: The market for Tussin DM is driven by the increasing prevalence of respiratory conditions and growing consumer awareness of OTC medications.
  • Regulatory Impact: Strict regulations against codeine use favor non-opioid expectorants like guaifenesin.
  • Pricing Stability: Prices are likely to remain stable due to competition from generics and other brands.
  • Regional Growth: North America and Asia-Pacific are key regions for market growth.
  • Compliance: Adherence to FDA regulations and patient safety measures is crucial.

FAQs

What are the active ingredients in Tussin DM?

Tussin DM contains dextromethorphan hydrobromide as a cough suppressant and guaifenesin as an expectorant[4].

What are the common uses of Tussin DM?

Tussin DM is used to temporarily relieve cough due to minor throat and bronchial irritation, and to help loosen phlegm and thin bronchial secretions[4].

How much does Tussin DM typically cost?

The cost of Tussin DM can range from $9 to $11 for a supply of 118-120 milliliters, depending on the pharmacy and formulation[2][5].

Are there generic versions of Tussin DM available?

Yes, generic versions of dextromethorphan/guaifenesin combinations are available, which can be more cost-effective for consumers[2][5].

What regions are expected to see significant growth in the Tussin DM market?

North America and the Asia-Pacific region are expected to witness significant growth due to various market and regulatory factors[3].

Sources

  1. Allied Market Research: Guaifenesin Market Size, Trends | Industry Report 2021 - 2030
  2. Drugs.com: Tussin DM Prices, Coupons, Copay Cards & Patient Assistance
  3. Data Bridge Market Research: Global Dextromethorphan Market – Industry Trends and Forecast to 2030
  4. Drugs.com: Tussin DM: Package Insert / Prescribing Information
  5. Drugs.com: Q-Tussin DM Prices, Coupons, Copay Cards & Patient Assistance

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.